1968
DOI: 10.1097/00007890-196805000-00043
|View full text |Cite
|
Sign up to set email alerts
|

Graft-vs-host reaction following a single blood transfusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

1974
1974
2008
2008

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…Patients with immunologic deficiencies sometimes develop fatal graftversus-host disease (GVH) following the transfusion of whole blood or blood components [2,5,6]. It has been suggested that if blood is rendered free of immunocompetent leukocytes before transfusion, this syndrome can be prevented [4,7].…”
Section: Introductionmentioning
confidence: 99%
“…Patients with immunologic deficiencies sometimes develop fatal graftversus-host disease (GVH) following the transfusion of whole blood or blood components [2,5,6]. It has been suggested that if blood is rendered free of immunocompetent leukocytes before transfusion, this syndrome can be prevented [4,7].…”
Section: Introductionmentioning
confidence: 99%
“…40,41 TA-GVHD is extremely rare and most commonly occurs in immunodeficient patients, although isolated reports of TA-GVHD in immunocompetent patients have been documented. [42][43][44] In summary, these preliminary data do not demonstrate a significantly increased rate of TA-MC in recipients of FrWB or plts compared with RBCs. Larger studies are needed to determine whether there is an increased rate of TA-MC in combat casualties transfused with FrWB.…”
Section: Discussionmentioning
confidence: 54%
“…21 In addition, transfusional GVHD in immunodeficient infants is characterized by the development of severe GVHD and aplastic anemia, as is transfusional GVHD in immunocompetent patients after open heart surgery. 22,23 In all the above examples, donor T-lymphocytes mediate host hematopoietic stem cell destruction and lead to the development of marrow aplasia and severe pancytopenia. However, unlike our experience, fatal GVHD developed in all the reported recipients.…”
Section: Resultsmentioning
confidence: 99%